Antiandrogenic, Maspin Induction, and Antiprostate Cancer Activities of Tanshinone IIA and Its Novel Derivatives with Modification in Ring A-Reference-Cited by-同舟云学术

Antiandrogenic, Maspin Induction, and Antiprostate Cancer Activities of Tanshinone IIA and Its Novel Derivatives with Modification in Ring A

Published:2012-01-06 Issue:2 Volume:55 Page:971-975
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liu Weiguo¹,Zhou Jinming¹,Geng Guoyan¹,Shi Qingwen¹²,Sauriol Francoise³,Wu Jian Hui¹⁴

Affiliation:

1. Segal Cancer Center and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, 3755 Cote-Ste-Catherine, Road, Montreal, Quebec H3T 1E2, Canada

2. Hebei Medical University, Hebei, China

3. Queen’s University, Kingston, Ontario K7L 3N6, Canada

4. Department of Oncology and Division of Experimental Medicine, McGill University, 546 Pine Avenue W, Montreal, Quebec H2W 1S6, Canada

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm2015292

Reference16 articles.

1. Androgen receptor: role and novel therapeutic prospects in prostate cancer

2. Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?

3. Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient

4. Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer

5. Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tanshinone analog inhibits castration-resistant prostate cancer cell growth by inhibiting glycolysis in an AR-dependent manner;Journal of Biological Chemistry;2024-04

2. PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics;European Journal of Medical Research;2023-11-06

3. Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer;Molecular Cancer Therapeutics;2023-05-04

4. The role of phytoandrogens for benign prostatic hyperplasia treatment;Acupuncture and Herbal Medicine;2023-01-18

5. Research Progress on Structural Optimization on the Lipid-Soluble Ingredients of Salvia miltiorrhiza;Chinese Journal of Organic Chemistry;2023